Policy, Law, Economics and Politics - Deepening Democracy through Access to Information
This privately-owned website is operated and maintained by Creamer Media
We have detected that the browser you are using is no longer supported. As a result, some content may not display correctly.
We suggest that you upgrade to the latest version of any of the following browsers:
         
close notification
22 May 2013
   
 
 
 
DOWNLOAD
 

Ms MP Matsoso, Director-General: Health, have determined in accordance with Regulation 21 of the Regulations Relating to a Transparent Pricing System for Medicines and Related Substances published in Government Gazette Number 28214 of 11 November 2005 that the following information must be submitted to the Directorate: Pharmaceutical Economic Evaluation (PEE) within the National Department of Health by a manufacturer or importer of the medicine or scheduled substance.
 

Edited by: Creamer Media Reporter
 
 
 
 
Advertisements:
 
 
 
 
 
 
 
 
 
 
 
 
  Related social media
 
Related social media terms:
 
 
 
 
 
 
 
 
 
  Topics on this page
 
 
 
Person
 
 
 
 
 
 
 
 
 
 
 
 
 
Online Publishers Association